Pricing Log in Create free account

BioNexus Gene Lab Corp. (BGLC) vs CitroTech Inc. (CITR)

BioNexus Gene Lab Corp. and CitroTech Inc. are both Specialty Chemicals companies. CitroTech Inc. is the larger, with a market value of $61.7M against $2.4M — 25.4× the size. CitroTech Inc. grew revenue faster over the last twelve months: −26.4% against −67.3%. BioNexus Gene Lab Corp. has the higher net margin (−82.4% vs −1,788.4%) and the higher return on invested capital (−37.2% vs −170.7%). Across the 17 metrics below, BioNexus Gene Lab Corp. leads on 12 and CitroTech Inc. on 5.

Valuation

Metric BGLC CITR Specialty Chemicals median
P/E n/m n/m 26.45
P/S 0.64 39.80 1.64
P/B 0.26 5.96 1.84
Price to free cash flow n/m n/m 21.25
EV/EBITDA 0.63 n/m 12.93
EV/Sales (0.47) 38.00 1.90
Earnings yield (151.81%) (58.40%) 2.47%
Free cash flow yield (42.55%) (14.54%) 2.20%

Profitability

Metric BGLC CITR Specialty Chemicals median
Gross margin 12.34% (0.70%) 27.84%
Operating margin (79.62%) (1,330.45%) 5.64%
Net margin (82.36%) (1,788.40%) 4.26%
Free cash flow margin (27.30%) (578.56%) 4.75%
Return on equity (33.66%) (431.05%) 3.73%
Return on assets (28.38%) (257.87%) 1.16%
Return on invested capital (37.16%) (170.74%) 3.21%

Growth

Metric BGLC CITR Specialty Chemicals median
Revenue growth (TTM) (67.27%) (26.37%) 7.03%
EPS growth (last fiscal year) (79.49%) (252.46%) (8.48%)
Revenue growth, 5-year CAGR (8.20%) — 6.27%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BGLC CITR Specialty Chemicals median
Debt to equity 0.01 0.01 0.59
Current ratio 6.08 8.77 2.16
Net debt to EBITDA 1.49 0.44 2.03

Dividend

Metric BGLC CITR Specialty Chemicals median
Dividend yield — — 1.84%
Payout ratio — — 0.40

Size

Metric BGLC CITR Specialty Chemicals median
Market cap 2.43m 61.65m 1.95b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack